Raymond James Trust’s Cognizant CTSH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.2M | Sell |
15,609
-184
| -1% | -$13.7K | 0.03% | 446 |
|
|
2024
Q2 | $1.07M | Sell |
15,793
-496
| -3% | -$33.6K | 0.03% | 455 |
|
|
2024
Q1 | $1.19M | Sell |
16,289
-1,293
| -7% | -$98.8K | 0.03% | 420 |
|
|
2023
Q4 | $1.33M | Sell |
17,582
-3,938
| -18% | -$272K | 0.04% | 385 |
|
|
2023
Q3 | $1.46M | Buy |
21,520
+90
| +0.4% | +$6.21K | 0.04% | 333 |
|
|
2023
Q2 | $1.4M | Sell |
21,430
-287
| -1% | -$17.8K | 0.04% | 343 |
|
|
2023
Q1 | $1.32M | Buy |
21,717
+364
| +2% | +$22.8K | 0.04% | 349 |
|
|
2022
Q4 | $1.22M | Buy |
21,353
+4,071
| +24% | +$239K | 0.04% | 355 |
|
|
2022
Q3 | $993K | Sell |
17,282
-848
| -5% | -$55.5K | 0.04% | 386 |
|
|
2022
Q2 | $1.22M | Buy |
18,130
+831
| +5% | +$63.6K | 0.04% | 334 |
|
|
2022
Q1 | $1.55M | Buy |
17,299
+1,265
| +8% | +$111K | 0.05% | 311 |
|
|
2021
Q4 | $1.42M | Buy |
16,034
+2,113
| +15% | +$170K | 0.04% | 338 |
|
|
2021
Q3 | $1.03M | Buy |
13,921
+388
| +3% | +$28.6K | 0.03% | 398 |
|
|
2021
Q2 | $937K | Sell |
13,533
-1,763
| -12% | -$131K | 0.03% | 419 |
|
|
2021
Q1 | $1.2M | Buy |
15,296
+6,034
| +65% | +$466K | 0.04% | 323 |
|
|
2020
Q4 | $759K | Sell |
9,262
-49
| -0.5% | -$3.73K | 0.03% | 409 |
|
|
2020
Q3 | $646K | Sell |
9,311
-4,545
| -33% | -$296K | 0.03% | 416 |
|
|
2020
Q2 | $787K | Buy |
13,856
+3,085
| +29% | +$166K | 0.04% | 351 |
|
|
2020
Q1 | $501K | Sell |
10,771
-90
| -0.8% | -$5.36K | 0.03% | 400 |
|
|
2019
Q4 | $674K | Sell |
10,861
-1,470
| -12% | -$90.9K | 0.03% | 397 |
|
|
2019
Q3 | $743K | Buy |
12,331
+1,855
| +18% | +$117K | 0.04% | 362 |
|
|
2019
Q2 | $665K | Sell |
10,476
-731
| -7% | -$48K | 0.04% | 372 |
|
|
2019
Q1 | $812K | Buy |
11,207
+1,270
| +13% | +$88.9K | 0.05% | 322 |
|
|
2018
Q4 | $630K | Sell |
9,937
-46
| -0.5% | -$3.2K | 0.04% | 341 |
|
|
2018
Q3 | $771K | Buy |
9,983
+415
| +4% | +$32.5K | 0.04% | 329 |
|
|
2018
Q2 | $756K | Buy |
9,568
+693
| +8% | +$54.5K | 0.05% | 325 |
|
|
2018
Q1 | $714K | Sell |
8,875
-644
| -7% | -$50.9K | 0.05% | 303 |
|
|
2017
Q4 | $676K | Buy |
9,519
+212
| +2% | +$15.5K | 0.05% | 314 |
|
|
2017
Q3 | $676K | Sell |
9,307
-1,032
| -10% | -$72.5K | 0.05% | 307 |
|
|
2017
Q2 | $686K | Sell |
10,339
-657
| -6% | -$41.7K | 0.05% | 306 |
|
|
2017
Q1 | $655K | Buy |
10,996
+1,016
| +10% | +$58.4K | 0.05% | 307 |
|
|
2016
Q4 | $559K | Buy |
+9,980
| New | +$534K | 0.04% | 328 |
|
|
2016
Q3 | – | Sell |
-8,332
| Closed | -$477K | – | 685 |
|
|
2016
Q2 | $477K | Buy |
8,332
+1,720
| +26% | +$104K | 0.04% | 339 |
|
|
2016
Q1 | $414K | Sell |
6,612
-1,377
| -17% | -$80.1K | 0.04% | 363 |
|
|
2015
Q4 | $480K | Buy |
+7,989
| New | +$515K | 0.04% | 339 |
|
|
2014
Q3 | – | Sell |
-4,383
| Closed | -$214K | – | 615 |
|
|
2014
Q2 | $214K | Buy |
4,383
+425
| +11% | +$20.7K | 0.02% | 535 |
|
|
2014
Q1 | $200K | Buy |
+3,958
| New | +$198K | 0.02% | 529 |
|
Other funds holding CTSH
Raymond James Trust's CTSH Position: Q3 2024 in Review
Raymond James Trust reduced its Cognizant (CTSH) stake by 1.2% in Q3 2024, selling an estimated $13.7K and leaving 15,609 shares worth $1.2M. The position accounts for 0.03% of the portfolio, ranked #446.
Raymond James Trust first reported a position in CTSH in Q1 2014 and has held it in 37 quarters since. The position peaked at $1.55M in Q1 2022. 953 funds tracked by Wall St. Rank hold CTSH as of Q3 2024.
- Raymond James Trust held 15,609 shares of Cognizant worth $1.2M as of Q3 2024.
- Raymond James Trust sold 184 Cognizant shares in Q3 2024, an estimated $13.7K.
- Cognizant made up 0.03% of Raymond James Trust's portfolio in Q3 2024, its #446 holding.
- Raymond James Trust first reported a position in Cognizant in Q1 2014 and has held it in 37 quarters since.
- Raymond James Trust's Cognizant position peaked at $1.55M in Q1 2022.
- 953 funds tracked by Wall St. Rank held Cognizant as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.